Literature DB >> 10846010

Mechanisms for isolated volume response to a bronchodilator in patients with COPD.

I Cerveri1, R Pellegrino, R Dore, A Corsico, P Fulgoni, K P van de Woestijne, V Brusasco.   

Abstract

We hypothesized that an altered effect of lung inflation on airway caliber may in part explain the isolated volume response to bronchodilators, i.e., an increase of forced vital capacity (FVC) without change in 1-s forced expiratory volume (FEV(1)). Small-airway caliber was measured by high-resolution computed tomography at functional residual capacity and total lung capacity in five chronic obstructive pulmonary disease patients with an isolated increase of FVC (FVC responders) and five with an increase of both FVC and FEV(1) (FVC-FEV(1) responders) after inhalation of salbutamol. In FVC-FEV(1) responders, the airway diameter increased with the cube root of increase in lung volume but was unchanged or even decreased in four of five FVC responders. FVC responders had more severe emphysema, as inferred from lung function and imaging studies, than FVC-FEV(1) responders. We speculate that longitudinal traction or space competition (Verbeken EK, Cauberghs M, and Van de Woestijne KP, J Appl Physiol 81: 2468-2480, 1996) are possible underlying mechanisms. We conclude that the isolated volume response to bronchodilators is associated with severe emphysema and likely results from an altered effect of lung inflation on airway caliber.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846010     DOI: 10.1152/jappl.2000.88.6.1989

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

1.  Association between airway caliber changes with lung inflation and emphysema assessed by volumetric CT scan in subjects with COPD.

Authors:  Alejandro A Diaz; Carolyn E Come; James C Ross; Raúl San José Estépar; MeiLan K Han; Stephen H Loring; Edwin K Silverman; George R Washko
Journal:  Chest       Date:  2011-09-22       Impact factor: 9.410

Review 2.  Systematic Review of the Association Between Laboratory- and Field-Based Exercise Tests and Lung Function in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Martin Bell; Iain Fotheringham; Yogesh Suresh Punekar; John H Riley; Sarah Cockle; Sally J Singh
Journal:  Chronic Obstr Pulm Dis       Date:  2015-07-08

3.  Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study.

Authors:  Mario Cazzola; Pierluigi Paggiaro; Paolo Palange; Leif Bjermer; Pilar Ausin; Lars-Goran Carlsson; Jan Ekelund; Jan Lotvall
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

4.  Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.

Authors:  Spyridon Fortis; Alejandro Comellas; Barry J Make; Craig P Hersh; Sandeep Bodduluri; Dimitris Georgopoulos; Victor Kim; Gerard J Criner; Mark T Dransfield; Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2019-07

5.  Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.

Authors:  Theodore A Omachi; Mark D Eisner; Alexis Rames; Lada Markovtsova; Paul D Blanc
Journal:  Respir Res       Date:  2011-03-23

6.  A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.

Authors:  James E Hansen; Asli G Dilektasli; Janos Porszasz; William W Stringer; Youngju Pak; Harry B Rossiter; Richard Casaburi
Journal:  Ann Am Thorac Soc       Date:  2019-12

7.  The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.

Authors:  Surya P Bhatt; Sandeep Bodduluri; Vrishank Raghav; Nirav R Bhakta; Carla G Wilson; Young-Il Kim; Michael Eberlein; Frank C Sciurba; MeiLan K Han; Mark T Dransfield; Arie Nakhmani
Journal:  Ann Am Thorac Soc       Date:  2019-08

8.  Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease.

Authors:  Simonetta Baldi; Claudio Fracchia; Claudio Bruschi; Roberto Dore; Roberto Maestri; Vito Brusasco; Riccardo Pellegrino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

9.  Bronchodilator responsiveness and reported respiratory symptoms in an adult population.

Authors:  Wan C Tan; Jean Bourbeau; Paul Hernandez; Kenneth R Chapman; Robert Cowie; J Mark FitzGerald; Shawn Aaron; Darcy D Marciniuk; Francois Maltais; A Sonia Buist; Denis E O'Donnell; Don D Sin
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

10.  Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population.

Authors:  Annette Kainu; Ari Lindqvist; Seppo Sarna; Bo Lundbäck; Anssi Sovijärvi
Journal:  Respir Res       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.